CVRx, Inc.
NASDAQ:CVRXMedical - Devices
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
Volume 0.37M
Average 0.30M
CVRX Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
CVRx, Inc.NASDAQ: CVRX
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities rises 2.8% from a year ago
Other current liabilities stood at $3.53M at the end of Q1 FY2026, up 2.8% from a year earlier and down 62.8% from the prior quarter. Over 3 fiscal years it compounded at +42.7% a year.
Context
- Other current liabilities amounted to 3.5% of total assets at the end of Q1 FY2026, up 0.9 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +2.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 9.48M USD
- Year-over-year change
- +67.1%
- 4-year CAGR
- +42.2%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.48M | +67.1% |
| FY2024 | 2024-12-31 | 5.67M | +38.2% |
| FY2023 | 2023-12-31 | 4.11M | +25.8% |
| FY2022 | 2022-12-31 | 3.26M | +40.6% |
| FY2021 | 2021-12-31 | 2.32M | — |
Other Current Liabilities vs competitors
How CVRX compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +2.8% is the 8th highest of 10, against a peer median of +34.0%.
- Other current liabilities amounts to 3.5% of total assets for CVRX, versus a peer median of 8.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $24.81M USD | +699.5% | — | 13.3% | |
| Mar 2026 | $17.31M USD | +135.8% | +38.1% | 16.8% | |
| Mar 2026 | $11.79M USD | +21.5% | +1.3% | 5.3% | |
| Mar 2026 | €10.66M EUR | +1.8% | -13.4% | 10.7% | |
| Mar 2026 | $9.85M USD | +56.2% | +25.6% | 2.7% | |
| Mar 2026 | $9.1M USD | -35.3% | -47.4% | 24.5% | |
| Mar 2026 | $8.83M USD | +72.3% | -6.2% | 8.0% | |
| Mar 2026 | $6.82M USD | +26.5% | +25.5% | 3.5% | |
| Dec 2025 | $5.16M USD | +34.0% | -14.6% | 3.2% | |
| Mar 2026 | $3.53M USD | +2.8% | +42.7% | 3.5% | |
| Peer median (excluding CVRX) | — | +34.0% | -2.4% | 8.0% | |
Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 142.07M | 106.19M | 90.57M | 105.93M | 75.71M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 2.56M | 5.5M | 7.55M | 9.27M | 10.67M |
| Inventory | 3.88M | 6.96M | 10.98M | 12.11M | 12.21M |
| Other Current Assets | 2.59M | 4.22M | 2.99M | 2.51M | 3.07M |
| Total Current Assets | 151.1M | 122.88M | 112.09M | 129.81M | 101.65M |
| Property, Plant & Equipment (Net) | 1.43M | 2.03M | 3.11M | 3.57M | 3.12M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 26K | 27K | 27K | 27K | 26K |
| Total Non-current Assets | 1.45M | 2.06M | 3.14M | 3.6M | 3.15M |
| Total Assets | 152.55M | 124.94M | 115.23M | 133.41M | 104.79M |
| Account Payables | 510K | 1.72M | 1.88M | 2.58M | 3.83M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 351K | 120K | 125K | 135K | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.32M | 3.26M | 4.11M | 5.67M | 9.48M |
| Total Current Liabilities | 5.91M | 8.09M | 7.86M | 10.76M | 13.32M |
| Long-term Debt | 0 | 6.75M | 29.22M | 49.27M | 50.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 681K | 805K | 1.04M | 1.45M | 1.36M |
| Total Non-current Liabilities | 681K | 7.67M | 31.42M | 51.6M | 52.15M |
| Total Liabilities | 6.59M | 15.76M | 39.28M | 62.36M | 65.47M |
| Common Stock | 204K | 207K | 209K | 253K | 263K |
| Retained Earnings | (394.75M) | (436.18M) | (477.38M) | (537.35M) | (590.65M) |
| Accumulated OCI | (198K) | (207K) | (207K) | (206K) | (203K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 145.96M | 109.18M | 75.95M | 71.06M | 39.32M |
| Total Debt | 0 | 7.09M | 30.61M | 50.43M | 50.79M |
| Net Debt | (142.07M) | (99.11M) | (59.96M) | (55.5M) | (24.92M) |
CVRx, Inc.
NASDAQ:CVRX
Intrinsic Alpha fair value
Locked
Current Price
$2.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.